Paper published: Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression

Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression was published today in Journal of the National Cancer Institute.

Read the paper · Publisher.

Browse all publications.